Stefan Lohmer is a co-founder of Axxam and served as the company’s Chief Executive Officer from its inception in 2001 until December 31, 2024. Effective January 1, 2025, Stefan has transitioned to the role of Board Member and Chairman of the Axxam Scientific Advisory Board, continuing to contribute his extensive expertise and visionary leadership to Axxam’s strategic direction.

Prior to founding Axxam, Stefan was the Director of Bayer’s Research Centre in Milan (Italy) and the Head of Genomics worldwide for Bayer AG. In this role, he was responsible for generating and managing Bayer’s external genomic alliance with Millennium Pharmaceuticals (Cambridge, USA). He joined Bayer at the corporate research center located in Wuppertal (Germany) in 1992.

Stefan holds a degree in Molecular Biology and Biochemistry from the Albertus Magnus University in Cologne (Germany) and completed his PhD at the Max-Planck-Institute for Plant Breeding in Cologne. He is an inventor on more than 20 patents and has authored more than 20 peer-reviewed publications.

Stefan is passionate about transformative science and creating companies.

“Never follow the path, always set the trail!”